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A B S T R A C T   
Constructing biomimetic structure and immobilizing antithrombus factors are two effective methods to ensure 
rapid endothelialization and long-term anticoagulation for small-diameter vascular grafts. However, few liter-
atures are available regarding simultaneous implementation of these two strategies. Herein, a nano-micro-fibrous 
biomimetic graft with a heparin coating was prepared via a step-by-step in situ biosynthesis method to improve 
potential endothelialization and anticoagulation. The 4-mm-diameter tubular graft consists of electrospun cel-
lulose acetate (CA) microfibers and entangled bacterial nanocellulose (BNC) nanofibers with heparin coating on 
dual fibers. The hybridized and heparinized graft possesses suitable pore structure that facilitates endothelia cells 
adhesion and proliferation but prevents infiltration of fibrous tissue and blood leakage. In addition, it shows 
higher mechanical properties than those of bare CA and hybridized CA/BNC grafts, which match well with native 
blood vessels. Moreover, this dually modified graft exhibits improved blood compatibility and endothelialization 
over the counterparts without hybridization or heparinization according to the testing results of platelet adhe-
sion, cell morphology, and protein expression of von Willebrand Factor. This novel graft with dual modifications 
shows promising as a new small-diameter vascular graft. This study provides a guidance for promoting endo-
thelialization and blood compatibility by dual modifications of biomimetic structure and immobilized bioactive 
molecules.   
1. Introduction 
Cardiovascular diseases (CVDs) cause millions of deaths per year 
which account for nearly 1/3 of worldwide total deaths. Currently, 
conducting revascularization surgery to replace the diseased blood 
vessels with autologous or allogenic grafts is the most frequently rec-
ommended treatment. Although high patency rate can be realized 
through these treatments, supply shortage of these grafts motivates the 
development of alternative grafts. In this context, many artificial 
vascular grafts have been developed using polyethylene terephthalate 
(Dacron) [1] and expanded polytetrafluoroethylene (ePTFE) [2]. 
Indeed, these synthetic grafts are successfully applied as large diameter 
(larger than 6 mm) blood vessel substitutes. However, unsatisfactory 
outcomes are noted when used as small-diameter (less than 6 mm) 
vascular grafts due to thrombosis and intimal hyperplasia [3]. To this 
end, much work has been done to seek suitable materials for small- 
diameter grafts and considerable improvements in endothelialization 
and anticoagulation have been demonstrated [4–9]. Despite these ad-
vancements, no grafts are satisfactory in clinics. Therefore, further im-
provements are required. 
Ideally, a graft should have biomimetic structure mimicking that of 
native blood vessels [10,11]. It is accepted that electrospinning is the 
most widely used technique to produce biomimetic grafts [12–15]. 
However, bare electrospun grafts have disadvantages: Firstly, the pores 
are larger than those in the basement membrane in tunica intima of 
natural blood vessels which contain nano (1–100 nm) and submicron 
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(100–1000 nm) pores [16], leading to leakage of blood; Secondly, the 
fiber diameter in electrospun grafts is often several hundreds of nano-
meters, which cannot cover the fiber range from tens to hundreds 
nanometers of native blood vessels [15]. To this end, incorporating 
nano-scaled fibers into the electrospun grafts would be beneficial from 
the biomimetic viewpoint. 
Apart from biomimetic structure, an ideal graft should also possess 
the ability to promote rapid endothelialization and prevent coagulation. 
An effective way is to conduct surface modification such that bioactive 
molecules and growth factors can be adsorbed and immobilized on the 
surface of fibrous grafts [3,17,18]. Among various bioactive molecules, 
heparin has gained considerable attention since it is an effective and 
widely used anticoagulant in clinics [13,19,20]. The use of heparin can 
not only minimize the formation of thrombus on artificial surfaces, but 
also inhibit the growth of smooth muscle cells [21]. However, there is no 
report in the literature regarding the dual promotions of incorporation 
of nano-scaled fibers into electrospun grafts and surface immobilization 
of heparin on dual fiber surfaces. 
Herein, we report a novel electrospun microfibrous cellulose acetate 
(CA) tubular graft with incorporated bacterial nanocellulose (BNC) 
nanofibers, in which CA is an acetylated cellulose that can be electro-
spun into microfibers and BNC is a natural nanofibrous material with 
diameters ranging from 20 nm to 80 nm, both being candidate materials 
for vascular grafts [22–25]. The CA microfibers and BNC nanofibers are 
surface immobilized with heparin and the resultant graft is abbreviated 
as CA/BNC-H. The incorporation of BNC into the CA electrospun graft 
was realized by step-by-step in situ biosynthesis [26–28] and heparin 
was immobilized onto dual fibers by grafting. The objectives of this work 
were to prepare the CA/BNC-H graft and determine how the incorpo-
ration of BNC nanofibers and immobilization of heparin affect the 
physiochemical properties of the CA electrospun graft and how blood 
platelets and endothelial cells (ECs) respond to the dual modifications. 
2. Materials and methods 
2.1. Materials 
The CA with a weight-average molecular weight of 4.0 × 104 g/mol 
was purchased from Shanghai Aladdin Bio-Chem Technology Co. Ltd., 
Shanghai, China. Absolute ethanol and acetic acid were provided by 
Xilong Science Ltd., Shantou, China. The materials used for BNC 
biosynthesis (yeast extract, tryptone, disodium phosphate, and so on) 
were purchased from Beijing Innochem Science & Technology Co., Ltd., 
China. All materials were used as received without further purification. 
2.2. Preparation of electrospun CA graft 
The electrospinning was conducted from a CA solution with a con-
centration of 15% (w/v), which was prepared by dissolving CA into an 
acetone/acetic acid mixture (v/v = 1/1) under constant stirring. Elec-
trospun CA graft was deposited on a cylinder receiver with a distance of 
15 cm to the needle, an applied voltage of 10 kV, a rotating speed of 100 
rpm, a relative humidity of 40%, and a mass flow rate of 5 mL/h at 
ambient temperature. The length, inner diameter, and the wall thickness 
of the obtained CA graft was 30 mm, 4 mm, and 1 mm, respectively. 
2.3. Incorporation of BNC nanofibers into CA graft 
First, a BNC pellicle was prepared by conventional static culture 
method. The bacterial strains (Komagataeibacter xylinus X-2) and culture 
medium were reported previously [28,29]. The resultant BNC pellicle 
was used as substrate for the step-by-step in situ biosynthesis of BNC 
inside the porous CA graft [30]. The culture medium (50 μL) was 
injected into the space between a silicone tube and the CA graft using a 
pipette gun to allow for in situ biosynthesis inside the CA graft (Fig. 1). 
The second injection of culture medium was followed 1 h after the in situ 
growth of BC within the CA scaffold at 37 ◦C. The injection and subse-
quent in situ biosynthesis was repeated 6 times at 1 h time intervals, 
yielding BNC nanofiber-incorporated CA (i.e., CA/BNC). The CA/BNC 
graft was obtained after boiling in 0.5 M NaOH solution, rinsing with 
deionized water to neutral, and freeze dried. 
2.4. Surface immobilization of heparin 
Typically, heparin powder was added to an 2-(4-Morpholino)etha-
nesulfonic acid (MES) solution with a heparin concentration of 0.5% (w/ 
v). Afterwards, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
(EDC) and N-hydroxysuccinimide (NHS) were added with a ratio of 
heparin:EDC:NHS = 1:1:0.6. The CA/BNC graft was then immersed into 
the solution at 37 ◦C for 4 h under shaking. Subsequently, the heparin- 
Fig. 1. Illustration of preparation of electrospun CA tubular graft with incorporated BNC nanofibers and surface heparinization.  
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immobilized CA/BNC (namely CA/BNC-H) graft was washed with 0.1 M 
Na2HPO4 twice to terminate the reaction. Then, 1 M NaCl solution was 
added to clean the graft 4 times and the solution was refreshed every 6 h. 
Finally, the CA/BNC-H graft (Fig. S1, Supplementary Material) was 
obtained by rinsing with deionized water until neutral and freeze dried. 
The resultant product was named CA/BNC-H1. Other samples (CA/BNC- 
H2, 3, and 4) were produced using the same procedure with heparin 
concentrations of 1%, 3%, and 5% (w/v), respectively. 
2.5. Characterization 
A field emission scanning electron microscope (SEM, Hitachi, 
SU8010, Japan) was used to analyze the morphologies of CA, CA/BNC, 
and CA/BNC-H grafts. Fiber diameter and pore size were measured using 
Nano Measurer 1.2 software by randomly selecting at least 10 SEM 
images. Atomic force microscopy (AFM, NT-MDT Prima) was employed 
to observe the surface morphologies of grafts. An X-ray diffractometer 
(XRD, 6100, Shimazu, Japan) was used to assess the crystal structure 
under 40 kV accelerating voltage and 30 mA current over a scanning 
range of 10–40◦. To determine the surface chemistry, Fourier transform 
infrared spectrometer (FTIR, PerkinElmer, Spectrum one, USA) was used 
at a resolution of 4 cm− 1. A thermal gravimetric analyzer (TGA, Perki-
nElmer, USA) was employed to test thermal stability under nitrogen 
flow. The samples were heated from 50 to 600 ◦C and the heating rate 
was set at 20 ◦C min− 1. A liquid/solid interface analyzer (Chengde 
Chenghui, JGM-360B) was used to measure the water contact angles. 
Mechanical properties were tested using a precise miniature elec-
tromagnetic fatigue testing machine (MUF-1050, Tianjin Care Measure 
& Control Co., Ltd., Tianjin, China) under a strain rate of 5 mm min− 1. 
The testing samples had the dimension of 10 mm × 5 mm × 2 mm. 
2.6. Release of heparin 
To quantitatively determine the heparin release from CA/BNC-H 
grafts, the sterilized samples (1 mm in thickness and 15 mm in diam-
eter) were immersed in 2 mL of PBS (phosphate buffered saline) solution 
and incubated at 37 ◦C under shaking at 120 rpm for 1, 2, 3, 5, 7, 10, 16, 
21, 28, and 35 days. At each time point, the release media (PBS con-
taining released heparin) was collected and renewed with fresh PBS. The 
collected liquid was used to test the heparin concentration using a 
heparin sodium detection kit (100 T, Ruichu Bio, Shanghai). 
2.7. Evaluation of blood compatibility 
The blood compatibility was evaluated by platelet adhesion test 
using platelet rich plasma (PRP) that was prepared using a procedure as 
previously reported [30] and circular CA, CA/BNC, and CA/BNC-H 
samples (1 mm in thickness and 15 mm in diameter). To quantita-
tively compare the blood compatibility, platelet adhesion was first 
tested by lactic acid dehydrogenase (LDH) release assay. Briefly, 100 μL 
of fresh PRP was pipetted onto the surface of each graft sample and 
incubated at 37 ◦C for 2 h. After removal of the PRP suspension, the 
samples were washed with PBS three times. Then, 150 μL of the lysis 
solution was dropped on the sample surfaces and incubated at 37 ◦C for 
1 h. Subsequently, a mixture of 120 μL of lysate and 80 μL of substrate 
solution was obtained and then centrifuged at 4000 rpm for 5 min. The 
supernatant was collected and the absorbance was read at 490 nm using 
a microplate reader (iMark, Bio Rad, California, USA). At the same time, 
the platelets adhered on sample surfaces were observed using the 
aforementioned SEM after fixation with 2.5 wt% glutaraldehyde solu-
tion, dehydration with a series of ethanol solution, air drying, and gold 
sputtering. 
2.8. Assessment of cytocompatibility 
Circular samples of CA, CA/BNC, and CA/BNC-H were sterilized at 
121 ◦C for 30 min and placed in a 24-well plate. The human umbilical 
vein endothelial (HUVEC) cells were seeded on the graft samples at a 
density of 1 × 104 cells per well. The incubation was carried out in 
endothelial cell medium (ENCM) supplemented with 10% fetal bovine 
serum (FBS) and 1% endothelial cell growth supplement (ECGS) for 1, 4, 
and 7 days at 37 ◦C in a 5% CO2 environment. Upon completion of in-
cubation, a routine Cell Counting Kit-8 (CCK-8) assay was conducted to 
assess the proliferation by measuring the absorbance at 450 nm using 
the aforementioned microplate reader, as reported previously [30]. 
Fluorescent cell images were obtained using live/dead assay. After 
incubation for 4 and 7 days under the aforementioned conditions and 
washing twice with PBS, cells on the samples were stained using a live/ 
dead staining reagent (fluorescein diacetate/PI, Solarbio, Beijing, 
China) in accordance with the manufacturer’s instructions and then 
observed using a fluorescence inverted microscope (TS2, Nikon, Tokyo, 
Japan). For quantitation, representative images were collected, and cell 
number was analyzed using ImageJ software (National Institutes of 
Health, USA). 
Cell morphologies on sample surfaces were examined using SEM 
after routine incubation, washing, fixation with 2.5 wt% glutaralde-
hyde, dehydration, freeze drying, and gold sputtering, as reported in our 
previous studies [30,31]. 
2.9. Cytoskeleton, nuclei, and immunofluorescent staining 
To observe cytoskeleton and nuclei, cellular actin cytoskeleton was 
stained with 100 nM of rhodamine phalloidin (Solarbio, Beijing, China) 
and cell nuclei were counter-stained with 5 μL/mL of 4,6-diamidino-2- 
phenylindole (DAPI, Solarbio, Beijing, China) for 20 s. The stained 
samples were then observed using a confocal laser scanning microscopy 
(CLSM, Leica SP8). For staining with the von Willebrand Factor (vWF), 
samples after 3 days of culture in 24-well plates filled with ENCM were 
fixed using 4% paraformaldehyde for 15 min, permeabilized using 0.2% 
TritonX–100 in PBS for 15 min, and blocked using 2% bovine serum 
albumin (BSA) for 40 min at 37 ◦C to reduce nonspecific staining. The 
blocked samples were stained using vWF (2% BSA diluted primary 
antibody) and then Alexa 488 (second antibody, diluted at 1:100 in 2% 
BSA). Finally, samples were washed, stained with rhodamine phalloidin 
for 30 min and DAPI for 30 s, and observed using the same CLSM. 
2.10. Statistical analysis 
Statistical analysis was performed using a Statistical Product and 
Service Solutions (SPSS) software (version 20). A statistical significance 
was considered when p-value is less than 0.05. 
3. Results 
3.1. Characterization of CA/BNC-H grafts 
SEM images (Fig. 2A) reveal the fibrous structure of CA, BNC, CA/ 
BNC, and CA/BNC-H grafts. CA has thick electrospun fibers and BNC 
shows nanofibrous and porous morphology, in consistent with previous 
reports [31,32]. CA/BNC and CA/BNC-H show entangled dual fibers of 
thick CA fibers and fine BNC fibers. There is no significant difference in 
morphology between CA/BNC-H1, 2, 3, and 4 although their heparin 
contents are different (Fig. S2, Supplementary Material). SEM cannot 
tell the difference in morphology between CA/BNC and CA/BNC-H. 
Nevertheless, AFM images (Fig. 2B) clearly demonstrate rougher sur-
face of CA/BNC-H3, as a model CA/BNC-H sample, as compared to CA 
and CA/BNC, which is due to the immobilization of heparin. The for-
mation of a heparin layer on the surface of the graft was also observed by 
other researchers [33], which is important for the blood compatibility 
[34]. Fig. 2C and D reveals that incorporation of BNC decreases the 
average pore size of CA (CA vs. CA/BNC), while heparin immobilization 
does not cause significant changes in the average fiber and pore sizes 
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(CA/BNC vs. CA/BNC-H). 
To determine the chemical state of heparin on BNC and CA fibers, 
XRD and FTIR analyses were conducted. As seen in Fig. 3A, three peaks 
at 14.2◦, 16.6◦, and 22.6◦ are observed, which are characteristic peaks of 
cellulose I [35]. There is a broad peak centered at around 22.6◦ in the 
XRD pattern of CA, which is consistent with previous reports [36,37]. 
The XRD pattern of heparin is similar to that reported by Zhao et al. 
[38]. The XRD patterns of CA/BNC and CA/BNC-H are similar to that of 
bare BNC except for an additional peak at around 20◦, which was also 
observed in our previous work [31]. 
Fig. 3B shows the FTIR spectra of CA, BNC, heparin, CA/BNC, and 
CA/BNC-H samples. All samples except heparin show a strong absorp-
tion peak at 2919 cm− 1, which is attributed to the stretching vibration of 
-CH2. The absorption peaks at 1640 cm− 1 and 1061 cm− 1 are attributed 
to the stretching of H–O–H and the asymmetric stretching vibration of C- 
O-C, respectively [39–41]. Note that CA presents a peak at 1740 cm− 1, 
which is attributable to the stretching vibration of the ester group C–O 
of CA molecule [42]. This peak is absent in the spectrum of CA/BNC due 
to the complete deacetylation by the NaOH treatment [31]. It is worth 
noting that the –OH peak of CA/BNC shifts from 3419 cm− 1 in BNC to 
3498 cm− 1, likely due to the hydrogen bond between CA and BNC [22], 
which is schematically illustrated in Fig. 3C. In the heparin spectrum, 
the absorption peaks at 807 cm− 1 (axial deformation of C-O-S), 1061 
cm− 1 (asymmetric stretching vibration of C-O-C), 1239 cm− 1 (S–O axial 
deformation), 1540 cm− 1 (N–H bending vibration and C–N tensile 
vibration) and 1640 cm− 1 (C–O stretching vibration) as well as the 
broad band between 3600 and 3100 cm− 1 (vibration stretching of –OH 
group) can be observed [43–45]. All these peaks can be found in the 
FTIR spectra of CA/BNC-H grafts, suggesting the presence of heparin in 
CA/BNC-H samples. Moreover, compared to CA/BNC, the peak intensity 
at 1640 cm− 1 in CA/BNC-H grafts is stronger and it increases with 
heparin content, which is mainly ascribed to the formation of a new 
ester bond between heparin and CA/BNC [46] (Fig. 3C), indicating the 
successful grafting of heparin. Note that the –OH peak shows a gradual 
shift from 3441 cm− 1 in CA/BNC to 3461 cm− 1 in CA/BNC-H4, likely 
caused by the formation of hydrogen bond between heparin and CA/ 
BNC [47], as illustrated in Fig. 3C. 
The TGA results (Fig. S3, Supplementary Material) of CA, BNC, 
heparin, CA/BNC, and CA/BNC-H demonstrate that all samples except 
heparin have three-stage curves. There are slight mass losses below 
Fig. 2. Morphologies of CA, BNC, CA/BNC, and CA/BNC-H grafts. (A) SEM micrographs. (B) AFM images. (C) Fiber diameter distribution. (D) Pore diameter 
distribution. 
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275 ◦C, mainly due to evaporation of physically adsorbed water [48]. 
Rapid mass losses are noted beyond 390 ◦C, due to a series of decom-
position processes such as chain depolymerization, dehydration, and 
pyrolysis of glucose [49]. It is worth noting that the water contents are 
different, among which heparin has the highest while BNC the lowest. 
The main reason is that heparin contains abundant hydrophilic groups 
such as carboxylate (-COO-) and sulfonate (-OSO3-), which can strongly 
interact with water molecules through dipole-dipole or ion-dipole [50]. 
TGA results suggest the decrease of thermal stability of CA/BNC-H as 
compared to CA/BNC, due to the addition of thermally unstable heparin, 
and the reduction increases with heparin content. 
Fig. S4 (Supplementary material) presents water contact angles of 
CA, BNC, CA/BNC, and CA/BNC-H samples. As expected, CA shows a 
very high contact angle of 121.2◦ since it is hydrophobic. After incor-
poration of BNC, a much lower contact angle (77.3◦) is found in CA/BNC 
due to the presence of hydrophilic BNC and NaOH treatment as 
mentioned above. More importantly, CA/BNC-H samples show signifi-
cantly lower contact angles (31.8–35.5◦) than that of CA/BNC due to the 
large number of hydrophilic groups on heparin, as displayed in FTIR 
spectra (Fig. 3B). 
Fig. 4 presents the mechanical properties of BNC, CA, CA/BNC, and 
CA/BNC-H grafts. The incorporation of BNC to CA greatly increases the 
tensile strength (Fig. 4A) and Young’s modulus (Fig. 4B) while the 
elongation at break (Fig. 4C) of CA/BNC is comparable to CA. More 
importantly, CA/BNC-H1, 2, 3, 4 samples show significantly higher 
tensile strength and elongation at break than CA/BNC (p < 0.05 in each 
Fig. 3. XRD (A) and FTIR (B) spectra of BNC, CA, CA/BNC, heparin, and CA/BNC-H grafts. (C) Proposed interactions between BNC, CA, and heparin.  
Fig. 4. Mechanical properties of CA, CA/BNC, and CA/BNC-H grafts. (A) Tensile strength. (B) Young’s modulus. (C) Elongation at break. *p < 0.05, **p < 0.01, n 
= 5. 
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case). This phenomenon was also reported by Lu et al. who claimed a 
significant increase (from 450 ± 30 kPa to 590 ± 7 kPa) in compressive 
strength when heparin was added to a fibroin/collagen scaffold [51]. 
3.2. Release of heparin from CA/BNC-H grafts 
The in vitro release profiles of heparin are shown in Fig. 5. Similar to 
many heparin immobilized scaffolds [13,51], there is an initial burst 
release of heparin from CA/BNC-H grafts. The release amounts from CA/ 
BNC-H3 are 18%, 37%, and 55% on the 1st, 3rd, and 10th days, 
respectively. After 21 days, the release amount stabilizes and the hep-
arin remained in CA/BNC-H3 is approximately 40%. The comparisons 
between CA/BNC-H1, 2, 3, and 4 reveal that the remained amount is 
inversely proportional to the heparin content (Fig. S2) in the grafts. 
3.3. Evaluation of platelet adhesion 
To investigate the effects of heparinization and hybridization on 
antithrombogenic properties, platelet adhesion test was carried out to 
assess the platelet adhesion and activation on CA, CA/BNC, and CA/ 
BNC-H3 (as a representative CA/BNC-H sample) grafts. A few platelets 
are observed on CA (Fig. 6A) because it is hydrophobic (Fig. S4). When 
BNC is incorporated, the CA/BNC becomes hydrophilic and it is colo-
nized by abundant platelets (Fig. 6B). Importantly, the platelets adhered 
on CA/BNC show irregular shape, suggesting activation, which differs 
from those on CA/BNC-H3. A comparison between Fig. 6B and C clearly 
suggests that immobilization of heparin on the surface of BNC and CA 
fibers substantially inhibits platelet adhesion onto the surface of CA/ 
BNC-H3. The number of adhered platelets on CA/BNC is higher than 
that on CA, and approximately 2.5-fold higher than that on CA/BNC-H3 
(Fig. 6D). Moreover, fewer platelets are adhered on CA/BNC-H3 as 
compared to CA. This result may suggest that CA/BNC-H3 has favorable 
antithrombogenic properties. 
3.4. Assessment of cytocompatibility and endothelialization 
To determine the effect of hybridization and heparinization on 
endothelialization, HUVEC cells were cultured on CA, CA/BNC, and CA/ 
BNC-H grafts. The cell adhesion and viability of HUVEC cells cultured on 
these grafts were evaluated using the live/dead staining and imaged 
with the fluorescence microscopy after incubation for 1, 4, and 7 days 
(Fig. 7A). Extensive cell population is observed across the surface of each 
graft and all grafts promote adhesion and growth of HUVEC cells after 
seeding for 4 days. Fig. 7B indicates that the density of living cells on 
CA/BNC-H3 is significantly higher as compared with CA and CA/BNC (p 
< 0.001). 
SEM was used to observe the cell morphology on each graft. The cells 
on CA (Fig. 8A) are smoother than those on CA/BNC (Fig. 8B), while the 
cells on CA/BNC-H3 show abundant filopodia (Fig. 8C), suggesting that 
the cells grow better on CA/BNC-H3. 
Quantitative cell viability and proliferation results are displayed in 
Fig. 8D. Although rapid cell proliferation is observed on each graft, cell 
viability (indicated by absorbance) is significantly different between CA, 
CA/BNC, and CA/BNC-H even on the first day. CA exhibits the lowest 
viability at each time point and a significant improvement is observed 
after hybridization with BNC fibers. Moreover, further increase in cell 
viability is observed when BNC and CA fibers are heparinized. These 
results reveal that both heparinization and hybridization enhance 
endothelialization of the CA graft. 
To further assess endothelialization and coverage by HUVEC cells, F- 
actin was stained with rhodamine phalloidin (red) and the nuclei were 
counter-stained with DAPI (blue), In addition, HUVEC cells were also 
stained for von vWF with green color. Fig. 9A shows the stained cells 3 
days post seeding. Overall, the HUVEC cells proliferate well and a layer 
of endothelium is formed on each graft. In addition, HUVEC cells were 
also stained for von vWF with green color (Fig. 9B). The expression level 
of vWF on CA/BNC-H3 is higher than that on CA and CA/BNC. 
4. Discussion 
Developing an applicable small-diameter vascular graft remains a 
huge challenge due to vexed thrombosis and intimal hyperplasia [3]. 
Anticoagulation and rapid endothelialization are two requirements in 
designing small-diameter grafts [52]. It has been well accepted that 
complete endothelialization can prevent the formation of thrombosis 
and intimal hyperplasia and thus rapid endothelialization is critical to 
the success of vascular grafts [53,54]. To this end, numerous strategies 
have been developed to promote the attachment, proliferation, and 
phenotypic maintenance of ECs on the surface of grafts because these 
processes occur on the surface of native extracellular matrix (ECM). The 
first method is to fabricate grafts with a structure analogous to native 
blood vessels [30] that are composed of three layers of tunica intima, 
tunica media, and tunica adventitia [10,55]. More specifically, the 
artificial grafts should have a structure bearing resemblance to tunica 
intima consisting of nano- to micro-scaled fibers, which is covered with a 
monolayer of ECs and determines the anti-thrombosis [12,56]. The 
second method is surface modification with bioactive molecules such as 
heparin because, in natural blood vessels, factors released by ECs play a 
critical role in promoting antithrombogenic nature [57]. Although the 
above-mentioned methods have been adopted individually by many 
researchers, few studies have investigated the control of blood 
compatibility and endothelialization by integrating dual modifications 
of structure imitation and surface immobilization. The present study 
aims at determining the combined effects of hybridization and hep-
arinization on blood compatibility and endothelialization. 
To mimic the structure of native blood vessels, BNC nanofibers were 
hybridized with CA microfibers, leading to a graft with biomimetic 
structure. On the one hand, the hybridization results in greatly 
decreased pore size: The CA shows an average pore size of around 22 μm 
with the largest pore size of 50 μm (Fig. 2). In sharp contrast, CA/BNC 
and CA/BNC-H3 presents a porous structure with an average pore 
diameter of around 10 μm (Fig. 2), which is smaller than the size of fi-
broblasts (approximately 15 μm [58]). Such pore size is believed to 
allow EC adhesion and proliferation and communication between ECs 
and smooth muscle cells (SMCs), while preventing fibrous tissue infil-
tration and blood leakage [58,59]. In other words, CA/BNC-H3 graft has 
a suitable pore size that facilitates endothelialization while minimizing 
the risk of fibrous tissue infiltration and blood leakage [54]. On the other 
hand, the hybridization also endows the CA/BNC and CA/BNC-H3 with 
biomimetic nano-micro-sized fibers. Our previous studies suggested that 
the graft with nano-micro-sized fibers presented enhanced Fig. 5. Release profiles of heparin from CA/BNC-H grafts.  
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endothelialization over the microfiber-only CA graft [30], which is 
consistent with the results presented in Fig. 7 that demonstrates more 
cells on CA/BNC than CA. This further suggests that hybridization can 
promote cell attachment and proliferation by providing biomimetic 
microenvironment for cells. Importantly, Fig. 7 also confirms that the 
largest cell number is observed on CA/BNC-H3, suggesting that heparin 
immobilization on a graft consisting of nano-micro-fibers can immensely 
promote EC attachment and proliferation, agreeing with previous 
studies [60,61]. According to our results, hybridization and heparin-
ization can effectively enhance the adhesion and viability of ECs and the 
combined effect is much higher than sole hybridization. In other words, 
there are synergistic effects between hybridization and heparinization in 
favoring endothelialization. 
We also evaluate cell attachment and proliferation by observing the 
cytoskeleton and nuclei organization of HUVEC cells (Fig. 9A). The 
HUVEC cells seeded on CA/BNC-H3 exhibit a wider spreading as 
compared to CA and CA/BNC. These results further suggest that hy-
bridization and heparinization promote endothelialization. Further-
more, we measured the expression of vWF (Fig. 9B). The result shows 
that dual modifications of hybridization and heparinization significantly 
promote the expression level of vWF in comparison to CA and CA/BNC. 
The vWF is a glycoprotein produced in Weibel-Palade bodies within the 
cytoplasm of ECs [62], which is a vital predictor of endothelialization 
[63] and plays a significant role in facilitating anticoagulation [64]. The 
significant up-regulation of vWF observed in the HUVEC cells grown on 
CA/BNC-H3 further approves the favorable role of dual modifications in 
Fig. 6. (A–C) SEM images of platelets adhered on CA (A), CA/BNC (B), and CA/BNC-H3 (C) grafts. (D) Quantification of adhered platelets measured by lactate 
dehydrogenase (LDH) activity after incubation of CA, CA/BNC and CA/BNC-H grafts in platelet-rich plasma (PRP). *p < 0.05, **p < 0.01, n = 5. 
Fig. 7. FDA (green, living cells)/PI (red, dead cells) staining microscopy images (A) and cell density (B) of HUVEC cells seeded on CA, CA/BNC, and CA/BNC-H grafts 
for 1, 4, and 7 days. Scale bar: 100 μm. **p < 0.01, ***p < 0.001, n = 5. (For interpretation of the references to color in this figure legend, the reader is referred to the 
web version of this article.) 
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promoting endothelialization and anticoagulation. 
Besides endothelialization, anticoagulation function was assessed as 
well. It is noted that the incorporation of BNC nanofibers to electrospun 
CA microfibers increases platelet adhesion due to the improved hydro-
philicity of CA/BNC graft (Fig. S4) [65,66]. Fortunately, CA/BNC-H3 
shows a significant reduction in platelet adhesion when compared to 
CA and CA/BNC (Fig. 6), suggesting the significant role of heparin in 
inhibiting platelet adhesion. 
All these results indicate that the CA/BNC-H3 can not only promote 
cell attachment and proliferation due to ECM-like structure, but also 
enhance antithrombogenic behavior through heparin immobilization. 
The mechanism is illustrated in Fig. 10. 
Besides excellent blood compatibility and endothelialization, 
matched mechanical performance to withstand the pressure of flowing 
blood is another critical requirement [67]. Although CA shows a rela-
tively low mechanical strength, CA/BNC and, particularly, CA/BNC-H3 
show sufficient mechanical performance. The mechanical testing results 
(Fig. 4) suggest that immobilizing heparin on fibrous materials can lead 
to improvements in strength, likely due to the interfacial interactions 
between heparin and CA/BNC as revealed by FTIR results (Fig. 3). Note 
that there is no difference in tensile modulus (p > 0.05) between CA/ 
BNC and CA/BNC-H grafts. The tensile strength of CA/BNC-H3 is larger 
than the maximum stress of coronary arteries (1.44 ± 0.87 MPa) 
measured by Karimi et al. [68], and almost equals to the fracture 
Fig. 8. (A–C) SEM images of HUVEC cells after seeding on CA (B), CA/BNC (C), and CA/BNC-H3 (D) for 3 days. Scale bar: 10 μm. (D) CCK-8 assay results. *p < 0.05, 
***p < 0.001, n = 5. 
Fig. 9. (A) CLSM images showing development of F-actin (red), nuclei (DAPI, blue), and vWF (green) in cells 3 days post seeding on CA, CA/BNC, and CA/BNC-H3 
grafts. Scale bar: 100 μm. (B) Relative expression level of vWF. **p < 0.01, n = 5. (For interpretation of the references to color in this figure legend, the reader is 
referred to the web version of this article.) 
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strength of human thoracic aorta (about 1.95 MPa) and the fracture 
strength of human femoral artery (1–2 MPa) [69]. The Young’s modulus 
is higher than that of coronary artery (0.7–2.1 MPa) [70], and the strain 
is comparable to that of native thoracic aorta (48%) [70]. These results 
indicate that the mechanical properties of CA/BNC-H3 are sufficient for 
a graft. In conjunction with the favorable blood compatibility and 
endothelialization, such mechanically matched graft shows promising in 
future applications in replacing damaged and diseased small-diameter 
blood vessels although further studies are required to evaluate their 
endothelialization in vivo and long-term patency. 
5. Conclusions 
BNC nanofibers were incorporated into the electrospun microfibrous 
CA graft to endow it with biomimetic architecture. The CA and BNC 
fibers in the CA/BNC graft were immobilized with heparin. The hy-
bridized and heparinized CA/BNC-H graft maintains the porous struc-
ture of bare CA and BNC grafts with an average pore size of around 10 
μm, which facilitates EC adhesion and proliferation and communication 
between ECs and SMCs, but inhibits fibrous tissue infiltration and pre-
vents blood leakage. The immobilized heparin on BNC and CA fibers 
exhibits sustained release yet an initial burst release is noted. The me-
chanical properties of the CA/BNC-H graft are greatly improved 
compared with bare CA graft and larger than CA/BNC, which are suf-
ficient as a mechanically matched graft. It is found that hybridization 
with BNC nanofibers cannot improve blood compatibility of CA graft 
while heparin coating greatly inhibits platelet adhesion and activation. 
Fluorescence microscopy and CLSM images of HUVEC cells seeded on 
CA, CA/BNC, and CA/BNC-H grafts suggest that either hybridization or 
heparinization can promote cell attachment and proliferation. The CA/ 
BNC-H graft with combined advantages of biomimetic architecture and 
heparin coating exhibits enhanced endothelialization and blood 
compatibility compared to CA and CA/BNC grafts. The method 
described here provides a simple and effective way for engineering 
vascular grafts with excellent blood compatibility and complete endo-
thelialization as well as compatible mechanical properties yet the in vivo 
investigation on the patency of the novel CA/BNC-H graft is required in 
future studies. 
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